Veeva Systems Announces CFO Departure and New Leadership Appointments

2024-04-01 | 8-K |Healthcare

Summary

On March 28, 2024, Veeva Systems Inc. announced the departure of Chief Financial Officer Brent Bowman, who will leave the company effective April 1, 2024. Tim Cabral, former CFO from 2010 to 2020, will serve as Interim CFO until a replacement is found. Additionally, Veeva appointed E. Nitsa Zuppas as President and Chief of Staff, and Stacey Epstein as Chief Marketing Officer, both effective April 1, 2024. Alan Mateo, Executive Vice President of Global Sales, will retire and transition to a part-time advisor role on April 30, 2024. Veeva also reiterated its financial guidance for the quarter and fiscal year ending January 31, 2025.

Profitelligence Alerts

Get alerts for VEEV

Be first to know when Veeva Systems Inc. files with the SEC.

Set Up Alerts →

Filing Categories

CFO Resignation New CFO Appointed President Resignation New President Appointed New COO Appointed Regulation FD Disclosure No viable tag

About Veeva Systems Inc.

Veeva Systems Inc. is a cloud-based software solutions provider focusing specifically on the life sciences industry. Its primary function is to develop and deliver specialized software tailored for companies in the pharmaceutical, biotechnology, and medical device sectors. Veeva's product suite includes applications for customer relationship management, content management, collaboration, and data analytics, facilitating enhanced operational efficiency and regulatory compliance. The company’s offerings are designed to optimize the critical aspects of a life sciences company's operations, such as clinical data management, regulatory submissions, and commercial activities. Veeva Systems plays a significant role in the growing digital transformation of the health-related industries, bridging the gap between advanced technological solutions and industry-specific requirements. Founded in 2007 and headquartered in Pleasanton, California, Veeva has established itself as a leader in its niche market, empowering its clients with innovative tools that streamline R&D processes and enhance their go-to-market capabilities.

Exchange: NYSE Industry: Health Information Services Company Website →

Official SEC Documents

View Full Filing on SEC.gov All VEEV Filings

VEEV Research

8Ks, insider trades, financials, technicals

SEC Alert Manager

Get alerts within 60 seconds of new filings